Skip to content

Biogen Reverses Course, Asks FDA To Approve Failed Alzheimer’s Drug

Biogen, a United States drug manufacturer, has asked the Food and Drug Administration (FDA), to approve their Alzheimer’s drug, Aducanumab. Their request is highly unusual, as it’s the same drug they suspended testing just seven months ago because it was ineffective in Phase-2 clinical trials.   The Biogen announcement, shocked the scientific community and the…

Read More

Supplements For Your Brain, Do They Really Help You?

Supplements to improve your brain function, cognition, and memory have been promoted by drug companies for years. The question is, do they really improve your brain health as promised? If so, why don’t these supplements have the approval of the Food and Drug Administration (FDA)? The absence of FDA approval speaks volumes. In fact, without…

Read More

This will close in 0 seconds

Scroll To Top